Trials / Terminated
TerminatedNCT01289938
Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Matthias Schwab · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Pharmacokinetic of Metoclopramide (MCP) in correlation to polymorphisms of CYP2D6 and Dopamine-D2-Receptor. Pharmacokinetic of Diphenhydramine (DPH) in correlation to polymorphisms of CYP2D6
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diphenhydramine | Diphenhydramine 50 mg oral once |
| DRUG | Metoclopramide | 10 mg i.v. metoclopramide once |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2011-02-04
- Last updated
- 2016-05-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01289938. Inclusion in this directory is not an endorsement.